Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: South Korea Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20072
20083
20094
20111
20121
20131
20144
20159
20161
20174
20184
20197
20207
202110
20226
20233
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Pfizer8
Hoffmann-La Roche5
Merck Sharp & Dohme LLC4
Clovis Oncology, Inc.3
AbbVie2
AstraZeneca2
Bayer2
Blueprint Medicines Corporation2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung75
Lung Neoplasms14
Neoplasm Metastasis13
Neoplasms13
Carcinoma6
Colorectal Neoplasms6
Melanoma6
Recurrence5
Adenocarcinoma3
Adenocarcinoma of Lung3

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.